SOURCE: Equity News Circuit

Equity News Circuit

February 25, 2013 08:45 ET

Free Research Reports on COG, ONXX, TXN and WBMD Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Feb 25, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Cabot Oil & Gas Corp. (NYSE: COG) shares gained 11.05 percent on more than three times the average daily volume Friday to close at $59.81 a share. Record production of 267.7 billion cubic feet equivalent, a year-over-year increase of 43 percent, helped the company surpass $1 billion in revenues for the first time in its history.

Find out more about Cabot Oil & Gas including full access to the free equity report at:

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) shares gained 11.98 percent on 4.40 million shares traded Friday to close at $78.31 a share. The company reported a Non net loss of $42.9 million, or $0.64 a share, in the fourth quarter, topping the average analyst estimate by 38 cents according to Bloomberg.

Find out more about Onyx Pharmaceuticals including full access to the free equity report at:

Texas Instruments Inc. (NASDAQ: TXN) shares surged 5.23 percent on more than double its average daily volume Friday to close at $34.18 a share. The company announced that it will raise its quarterly dividend 33 percent to $0.28 per share and has authorized $5 billion of share buybacks. Texas Instruments now offers investors a dividend yield of approximately 3.28 percent.

Find out more about Texas Instruments including full access to the free equity report at:

WebMD Health Corp. (NASDAQ: WBMD) shares soared 25.4 percent on more than ten times its average daily volume Friday to close at $20.44 a share. The company's fourth quarter revenues of $132.7 million topped analysts' estimate of $124.14 million. Stifel Nicolaus has recently upgraded the company's rating to "buy" from "hold."

Find out more about WebMD Health including full access to the free equity report at:

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information